Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT
Apogee Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -237.67M | -205.39M | -182.15M | -146.66M | -118.48M | -103.55M | -83.98M | -66.26M | -65.07M | -46.19M | -33.67M | -19.66M | -6.12K | -4.3K |
Depreciation & Amortization | 730K | 367K | 189K | 113K | 65K | 29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 35.92M | 30.27M | 23.33M | 17.93M | 13.6M | 9.02M | 6.1M | 6.03M | 4.53M | 3.42M | 2.14M | n/a | n/a | n/a |
Other Working Capital | -12.17M | -1.78M | -930K | 5.37M | 7.78M | 803K | 4.49M | 4.74M | -1.48M | 5.18M | 4.97M | 3.24M | 3.32K | 1.72K |
Other Non-Cash Items | -3.75M | -5.67M | -6.59M | -7.12M | -8.19M | -5.42M | -2.97M | 341.34K | 9.72M | 9.71M | 9.72M | 9.15M | 2.8K | 2.58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -15.97M | -7.59M | -5.96M | 2.52M | 2.44M | 4.1M | 6.11M | 5.7M | 9.28M | 6.08M | 5.39M | 3.27M | 3.32K | 1.72K |
Operating Cash Flow | -220.74M | -188.01M | -171.17M | -133.21M | -110.57M | -95.84M | -74.76M | -54.2M | -41.55M | -26.98M | -16.43M | -7.24M | n/a | n/a |
Capital Expenditures | -5.83M | -5.12M | -1.15M | -1.32M | -569K | -518K | -167K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -442.17M | -621.76M | -649.45M | -658.39M | -656.6M | -429.63M | -303.74M | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 439.1M | 391.14M | 350.14M | 273.19M | 182.81M | 104.5M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -234.22M | -234.22M | -234.22M | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -8.9M | -235.74M | -300.46M | -620.74M | -708.58M | -559.87M | -508.13M | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 24K | 24K | 1.72M | 24K | n/a | 173.8K | 3.33M | 5.02M | 5.03M | 4.85M | 4.97K | 5K |
Financial Cash Flow | 46.54M | 45.21M | 495.11M | 450.54M | 767.46M | 765.91M | 315.39M | 315.78M | 3.33M | 5.02M | 5.03M | 4.85M | 4.97K | 5K |
Net Cash Flow | -183.11M | -378.54M | 23.47M | -69.49M | 182.23M | 344.12M | -33.57M | 185.69M | 122.48M | 138.75M | 149.31M | 2.58K | 4.97K | 5K |
Free Cash Flow | -226.58M | -193.13M | -172.33M | -134.53M | -111.14M | -96.36M | -74.93M | -54.2M | -41.55M | -26.98M | -16.43M | -7.24M | n/a | n/a |